Evidence map›Paper›PMID 32025658›Full record

ArticleInternational journal of pharmaceutics: X2020

A micro-XRT image analysis and machine learning methodology for the characterisation of multi-particulate capsule formulations.

Frederik J S Doerr, Alastair J Florence

Abstract read
In one paragraph

Article in International journal of pharmaceutics: X, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Characterization of Pharmaceutical Tablets by X-ray Tomography.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Frederik J S DoerrEPSRC CMAC Future Manufacturing Research Hub, Technology and Innovation Centre, 99 George Street, Glasgow G1 1RD, UK.
Alastair J FlorenceEPSRC CMAC Future Manufacturing Research Hub, Technology and Innovation Centre, 99 George Street, Glasgow G1 1RD, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The application of X-ray microtomography for quantitative structural analysis of pharmaceutical multi-particulate systems was demonstrated for commercial capsules, each containing approximately 300 formulated ibuprofen pellets. The implementation of a marker-supported watershed transformation enabled the reliable segmentation of the pellet population for the 3D analysis of individual pellets. Isolated translation- and rotation-invariant object cross-sections expanded the applicability to additional 2D image analysis techniques. The full structural characterisation gave access to over 200 features quantifying aspects of the pellets' size, shape, porosity, surface and orientation. The extracted features were assessed using a ReliefF feature selection method and a supervised Support Vector Machine learning algorithm to build a model for the detection of

Indexed as

Abbreviation, DescriptionClassification modelFeature selectionIEV, Translation- and rotation-invariant cross-sectionMachine learningMicro-XRT particle analysisOC-SVM, One-class support vector machineOSH, Optimal separating hyperplanePharmaceutical formulationRBF, Radial basis functionROI, Region-of-interestSensitivity analysisTC-SVM, Two-class support vector machineV_CP, Pellet populationV_CP_Poros, Pellet population porosityV_CP_ROI, Pellet population region-of-interestV_CS, Capsule shellV_CS_InV, Capsule shell internal volumeV_CS_Poros, Capsule shell voidV_CS_ROI, Capsule shell region-of-interestV_ROI, Single pellet region-of-interestV, Single pelletWatershed image segmentation

Identifiers

PMID32025658
PMCPMC6997304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.